膳食与组织α-亚麻酸水平与全因、心血管及癌症死亡风险的系统综述与剂量反应荟萃分析
该系统综述与剂量反应荟萃分析纳入41项前瞻性队列研究、共1 197 564名参与者,评估膳食摄入与组织生物标志物α-亚麻酸(ALA)与全因、心血管病(CVD)及癌症死亡风险的关联。结果显示较高ALA摄入与全因、CVD及冠心病死亡风险降低相关,癌症死亡风险略升高;组织ALA水平较高仅与全因和冠心病死亡风险降低相关。
要点
- 较高膳食ALA摄入与全因、CVD及冠心病死亡风险降低相关。
- 每日增加1 g ALA摄入与全因和CVD死亡风险各降低5%相关。
- 较高膳食ALA摄入与癌症死亡风险略升高相关,组织ALA水平未见此关联。
核心结论
- 膳食ALA摄入与全因、CVD和冠心病死亡风险降低相关,与癌症死亡风险略升高相关。
- 较高血液ALA水平仅与全因和冠心病死亡风险降低相关。
研究设计与样本
- 系统综述与前瞻性队列研究的剂量反应荟萃分析,检索PubMed、Scopus、ISI Web of Science和Google Scholar至2021年4月30日。
- 共纳入41篇文章,合计1 197 564名参与者,随访2至32年。
- 随访期间记录全因死亡198 113例、CVD死亡62 773例、癌症死亡65 954例。
主要发现
- 较高 versus 较低ALA摄入的全因死亡汇总相对风险为0.90(95%CI 0.83–0.97,I2=77.8%,15项研究)。
- 较高 versus 较低ALA摄入的CVD死亡汇总相对风险为0.92(95%CI 0.86–0.99,I2=48.2%,16项研究)。
- 较高 versus 较低ALA摄入的冠心病死亡汇总相对风险为0.89(95%CI 0.81–0.97,I2=5.6%,9项研究)。
- 较高 versus 较低ALA摄入的癌症死亡汇总相对风险为1.06(95%CI 1.02–1.11,I2=3.8%,10项研究)。
- 较高 versus 较低组织ALA水平的全因死亡汇总相对风险为0.95(95%CI 0.90–0.99,I2=8.2%,26项研究)。
关键数值与推荐
- 每日ALA摄入增加1 g与全因死亡风险降低5%相关(RR 0.95,95%CI 0.91–0.99,I2=76.2%,12项研究)。
- 每日ALA摄入增加1 g与CVD死亡风险降低5%相关(RR 0.95,95%CI 0.91–0.98,I2=30.7%,14项研究)。
- 血液ALA浓度每增加1个标准差与冠心病死亡风险降低8%相关(RR 0.92,95%CI 0.86–0.98,I2=37.1%,14项研究)。
临床怎么用
- 可将适量增加膳食ALA摄入作为改善心血管健康的饮食建议之一。
- 对癌症死亡风险的潜在轻微升高需在个体化饮食指导中权衡。
- 血ALA水平可用于评估与全因及冠心病死亡风险的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer. DESIGN: Systematic review and meta-analysis of prospective cohort studies. DATA SOURCES: PubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021. STUDY SELECTION: Prospective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer. DATA SYNTHESIS: Summary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality. RESULTS: 41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14). CONCLUSIONS: The findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42021229487.
引用
- Naghshi S, Aune D, Beyene J, et al. Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies. BMJ. 2021. PMID: 34645650. doi:10.1136/bmj.n2213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。